GaryMishkinMD

PubMed

• 21 citations
  Clinical use of high-efficiency hemodialysis treatments: long-term assessment.
  Juan P. Bosch, Susie Q. Lew, Viroj Barlee, Gary J. Mishkin, Beat von Albertini> ;Hemodialysis International. International Symposium on Home Hemodialysis. 2006 Jan 1
• In vitro performance of hemodialysis membranes after repeated processing
  Adam Johnson, Gary J. Mishkin, Susie Q. Lew, Mark Mishkin, Fred P. Abramson, Paolo Lecchi> ;American Journal of Kidney Diseases. 2003 Sep 1
• 31 citations
  Biocompatibility of Hemodialysis Membranes: Interrelations between Plasma Complement and Cytokine Levels
  Maria P. Varela, Paul L. Kimmel, Terry M. Phillips, Gary J. Mishkin, Susie Q. Lew, Juan P. Bosch> ;Blood Purification. 2001 Jan 1
• 117 citations
  Interdialytic weight gain and survival in hemodialysis patients: Effects of duration of ESRD and diabetes mellitus
  Paul L. Kimmel, Maria P. Varela, Rolf A. Peterson, Karen L. Weihs, Samuel J. Simmens, Sylvan Alleyne, Amali Amarashinge, Gary J. Mishkin, Illuminado Cruz, Judith H. Veis> ;Kidney International. 2000 Mar 1
• 5 citations
  Hemofiltration and double high flux dialysis: risks and benefits.
  Juan P. Bosch, Gary J. Mishkin> ;Current Opinion in Nephrology and Hypertension. 1998 Nov 1
• 19 citations
  Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients.
  M. T. Velasquez, Susie Q. Lew, B. von Albertini, Gary J. Mishkin, Bosch Jp> ;Clinical Nephrology. 1997 Dec 1
• 103 citations
  Captopril and renal survival in patients with human immunodeficiency virus nephropathy
  Paul L. Kimmel, Gary J. Mishkin, Walter O. Umana> ;American Journal of Kidney Diseases. 1996 Aug 1
• Compatibility of electrolytically produced sodium hypochlorite solutions on long- term implanted dialysis catheters.
  Mishkin, G. J.> ;Contrib Nephrol. 2007
• What clinically important advances in understanding and improving dialyzer function have occurred recently?
  Ward, R. A., Leypoldt, J. K., Clark, W. R., Ronco, C., Mishkin, G. J., Paganini, E. P.> ;Semin Dial. 2001 May 01
• The impact of residual renal function and total body water volume on achieving adequate dialysis in CAPD.
  Gao, H., Lew, S. Q., Ronco, C., Mishkin, G. J., Bosch, J. P.> ;J Nephrol. 1999 Aug 10
• Dialyzer reuse and the treatment of patients with end-stage renal disease by hemodialysis.
  Kimmel, P. L., Mishkin, G. J.> ;J Am Soc Nephrol. 1998 Nov
• Assessment of PD treatment delivered by 125I-Iothalamate plasma disappearance.
  Mishkin, G. J., Lew, S. Q., Bosch, J. P.> ;Clin Nephrol. 1998 Mar
• Equal levels of blood pressure control in ESRD patients receiving high-efficiency hemodialysis and conventional hemodialysis.
  Velasquez, M. T., von Albertini, B., Lew, S. Q., Mishkin, G. J., Bosch, J. P.> ;Am J Kidney Dis. 1998 Apr
• The development of high efficacy dialysis and how it can improve outcomes.
  Bosch, J. P., Mishkin, G. J.> ;Nephrol News Issues. 1997 Feb
• Responses to questions frequently asked by medical students about family practice.
  Scherger, J. E., Beasley, J. W., Brunton, S. A., Hudson, T. W., Mishkin, G. J., Patric, K. W., Olson, S. H.> ;J Fam Pract. 1983 Dec
• Join now to see all